PharmiWeb.com - Global Pharma News & Resources
19-Dec-2018

DP1 Receptor (Prostaglandin D2 receptor) Antagonist - Pipeline Insight 2018 - ResearchAndMarkets.com

The "DP1 Receptor (Prostaglandin D2 receptor) Antagonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'DP1 Receptor (Prostaglandin D2 receptor) Antagonist - Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across DP1 Receptor (Prostaglandin D2 receptor) Antagonist development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for DP1 Receptor (Prostaglandin D2 receptor) Antagonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. DP1 Receptor (Prostaglandin D2 receptor) Antagonist - Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. DP1 Receptor (Prostaglandin D2 receptor) Antagonist Pipeline Products in Clinical Stages

6. DP1 Receptor (Prostaglandin D2 receptor) Antagonist Pipeline Products in Non-clinical Stages

7. Therapeutic Assessment: Active Products

8. Inactive Pipeline Products

Companies Mentioned
  • Merck Sharp & Dohme
  • Ligand Pharmaceuticals
  • Atopix Therapeutics
  • AstraZeneca
  • 7TM Pharma
  • Shionogi
  • Novartis
  • Boehringer Ingelheim
  • Actelion Pharmaceuticals

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/5w6w73/dp1_receptor?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181219005350/en/

Editor Details

Last Updated: 19-Dec-2018